行情

MYL

MYL

迈兰实验室
NASDAQ

实时行情|Nasdaq Last Sale

17.26
-0.01
-0.06%
已收盘, 18:21 11/14 EST
开盘
17.15
昨收
17.27
最高
17.33
最低
16.87
成交量
790.40万
成交额
--
52周最高
35.45
52周最低
16.63
市值
89.08亿
市盈率(TTM)
165.01
分时
5日
1月
3月
1年
5年

分析师评级

18位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

MYL 新闻

  • Biogen shares fall 3%
  • MarketWatch.15小时前
  • Biogen Sheds $3 Billion in Value on Top Drug’s Patent Review
  • Bloomberg.18小时前
  • Pfizer Stock Is A Top Pharma Company — But Should You Buy It?
  • Investor's Business Daily.20小时前
  • FDA warns Mylan over quality issues at India site
  • seekingalpha.1天前

更多

所属板块

制药
-0.36%
制药与医学研究
-0.27%

热门股票

名称
价格
涨跌幅

MYL 简况

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic, brand name and over-the-counter (OTC) products in a range of dosage forms and therapeutic categories. It operates through three segments on a geographic basis, North America, Europe and Rest of World. The Company's Cold-EEZE family of brands includes OTC cold remedies sold as lozenges, gummies, oral sprays, caplets, QuickMelts and oral liquid dose forms in the United States. The North America segment primarily develops, manufactures, sells and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream or ointment form. The Europe segment sells pharmaceuticals under their International Nonproprietary Name (INN), such as active pharmaceutical ingredient (API), in certain European countries. The Rest of World segment is primarily made up of its operations in India, Australia, Japan and New Zealand.
展开

Webull提供Mylan NV的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。